Q2 2017 Holdings
Filed 2017-08-15 | 64 holdings | $82.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $35.0M | 681,165 | 42.4% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $30.4M | 1,094,983 | 36.8% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $10.8M | 698,392 | 13.1% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $2.6M | 94,560 | 3.1% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $2.0M | 332,310 | 2.5% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $178.0K | 12,110 | 0.2% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $134.7K | 16,093,786 | 0.2% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $121.3K | 12,043,932 | 0.1% |
| Penumbra Inc(PEN) | COM | 70975L107 | $81.7K | 931,444 | 0.1% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $75.2K | 860,456 | 0.1% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $71.6K | 764,389 | 0.1% |
| Juno Therapeutics Inc | COM | 48205A109 | $66.3K | 2,219,616 | 0.1% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $57.3K | 828,574 | 0.1% |
| Inc Resh Hldgs Inc | CL A | 45329R109 | $49.2K | 841,418 | 0.1% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $44.6K | 444,936 | 0.1% |
| Anthem Inc(ELV) | COM | 036752103 | $43.6K | 231,886 | 0.1% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $41.4K | 2,224,407 | 0.1% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $38.3K | 2,734,044 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $37.1K | 5,212,736 | 0.0% |
| Oxford Immunotec Global PLC | ORD SHS | G6855A103 | $36.3K | 2,155,949 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $34.4K | 665,139 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $33.9K | 1,718,671 | 0.0% |
| Centene Corp del(CNC) | COM | 15135B101 | $31.8K | 398,200 | 0.0% |
| Endologix Inc | COM | 29266S106 | $31.0K | 6,368,299 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $27.9K | 1,459,616 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $27.6K | 509,698 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $25.8K | 218,000 | 0.0% |
| Array Biopharma Inc | NOTE 3.000% 6/0 | 04269XAA3 | $25.7K | $19,000,000 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $25.5K | 2,223,811 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $25.1K | 1,187,494 | 0.0% |
| Spectranetics Corp | COM | 84760C107 | $24.4K | 634,802 | 0.0% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $23.0K | 1,223,334 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $22.9K | 4,207,575 | 0.0% |
| ICU MED Inc(ICUI) | COM | 44930G107 | $22.9K | 132,505 | 0.0% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $21.2K | 713,280 | 0.0% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $20.2K | 476,341 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $18.6K | 367,537 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $18.6K | 144,408 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $17.3K | 631,283 | 0.0% |
| Neuroderm LTD | ORD SHS | M74231107 | $16.6K | 555,096 | 0.0% |
| Nxstage Medical Inc | COM | 67072V103 | $16.5K | 657,356 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $16.0K | 1,138,370 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $15.7K | 973,260 | 0.0% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $14.3K | 866,819 | 0.0% |
| Clovis Oncology Inc(CLVSEUR)Call | COM | 189464100 | $14.2K | 152,000 | 0.0% |
| Cascadian Therapeutics Inc | COM NEW | 14740B606 | $13.9K | 3,735,994 | 0.0% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $13.0K | 212,028 | 0.0% |
| Model N Inc(MODNEUR) | COM | 607525102 | $11.4K | 858,314 | 0.0% |
| Puma Biotechnology IncCall | CALL | 74587V907 | $8.9K | 101,500 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $8.3K | 1,596,275 | 0.0% |